The correlation between BMI and COVID-19 outcomes
Abstract
Laith Khasawneh, Khaled Al-Omar, Amjed Adnan Tarifi, Dua'a Mohammad Khalil Shaout, Sara Yaser Awni Abu-Ghazal, Thshreen Sultan Mohammad alfazzaâa.
Background: The novel coronavirus (SARS-CoV-2) disease spread all over the world and lead to global pandemic, has different outcomes on patients depends on many factors, such as comorbidity, obesity, age and associated with significant morbidity and mortality.
Objective: the study amid to determine the effect of abnormal BMI in patients with coronavirus disease (COVID-19) on their disease outcomes.
Methods: the study involved analyzing the data of 210 post COVID-19 patients, which was collected through answering specific questions related to the relation of dieses outcomes and patients BMI.
Results: the mean age of patients was 34.7, 77 were female and 133 were males, 11% did suffer from shortness of breath of those who suffered from shortness of breath 70% were overweight and above normal BMI. 60% of moderately obese and 85% of severely obese people show symptoms for more than a week.
Conclusions: There is a correlation between BMI and COVID-19 outcomes, represented through moderate and severe obese patients were suffered from COVID-19 symptoms for longer duration than others.
| How to Cite this Article |
| Pubmed Style Mohammad Rudiansyah, Leonardo Lubis, Ria Bandiara, Bernadet Maria Sanjaya, Hendra Wana Nur'amin, Huldani, Abdul Hadi Martakusumah, Harun Achmad, Rully Marsis Amirullah Roesli, Dedi Rachmadi. The Correlation between Fibroblast Growth Factor 23 (FGF23) and Iron Profile in Chronic Kidney Disease Patients on Dialysis with Anemia. SRP. 2020; 11(6): 780-784. doi:10.31838/srp.2020.6.114 Web Style Mohammad Rudiansyah, Leonardo Lubis, Ria Bandiara, Bernadet Maria Sanjaya, Hendra Wana Nur'amin, Huldani, Abdul Hadi Martakusumah, Harun Achmad, Rully Marsis Amirullah Roesli, Dedi Rachmadi. The Correlation between Fibroblast Growth Factor 23 (FGF23) and Iron Profile in Chronic Kidney Disease Patients on Dialysis with Anemia. http://www.sysrevpharm.org/?mno=119061 [Access: March 29, 2021]. doi:10.31838/srp.2020.6.114 AMA (American Medical Association) Style Mohammad Rudiansyah, Leonardo Lubis, Ria Bandiara, Bernadet Maria Sanjaya, Hendra Wana Nur'amin, Huldani, Abdul Hadi Martakusumah, Harun Achmad, Rully Marsis Amirullah Roesli, Dedi Rachmadi. The Correlation between Fibroblast Growth Factor 23 (FGF23) and Iron Profile in Chronic Kidney Disease Patients on Dialysis with Anemia. SRP. 2020; 11(6): 780-784. doi:10.31838/srp.2020.6.114 Vancouver/ICMJE Style Mohammad Rudiansyah, Leonardo Lubis, Ria Bandiara, Bernadet Maria Sanjaya, Hendra Wana Nur'amin, Huldani, Abdul Hadi Martakusumah, Harun Achmad, Rully Marsis Amirullah Roesli, Dedi Rachmadi. The Correlation between Fibroblast Growth Factor 23 (FGF23) and Iron Profile in Chronic Kidney Disease Patients on Dialysis with Anemia. SRP. (2020), [cited March 29, 2021]; 11(6): 780-784. doi:10.31838/srp.2020.6.114 Harvard Style Mohammad Rudiansyah, Leonardo Lubis, Ria Bandiara, Bernadet Maria Sanjaya, Hendra Wana Nur'amin, Huldani, Abdul Hadi Martakusumah, Harun Achmad, Rully Marsis Amirullah Roesli, Dedi Rachmadi (2020) The Correlation between Fibroblast Growth Factor 23 (FGF23) and Iron Profile in Chronic Kidney Disease Patients on Dialysis with Anemia. SRP, 11 (6), 780-784. doi:10.31838/srp.2020.6.114 Turabian Style Mohammad Rudiansyah, Leonardo Lubis, Ria Bandiara, Bernadet Maria Sanjaya, Hendra Wana Nur'amin, Huldani, Abdul Hadi Martakusumah, Harun Achmad, Rully Marsis Amirullah Roesli, Dedi Rachmadi. 2020. The Correlation between Fibroblast Growth Factor 23 (FGF23) and Iron Profile in Chronic Kidney Disease Patients on Dialysis with Anemia. Systematic Reviews in Pharmacy, 11 (6), 780-784. doi:10.31838/srp.2020.6.114 Chicago Style Mohammad Rudiansyah, Leonardo Lubis, Ria Bandiara, Bernadet Maria Sanjaya, Hendra Wana Nur'amin, Huldani, Abdul Hadi Martakusumah, Harun Achmad, Rully Marsis Amirullah Roesli, Dedi Rachmadi. "The Correlation between Fibroblast Growth Factor 23 (FGF23) and Iron Profile in Chronic Kidney Disease Patients on Dialysis with Anemia." Systematic Reviews in Pharmacy 11 (2020), 780-784. doi:10.31838/srp.2020.6.114 MLA (The Modern Language Association) Style Mohammad Rudiansyah, Leonardo Lubis, Ria Bandiara, Bernadet Maria Sanjaya, Hendra Wana Nur'amin, Huldani, Abdul Hadi Martakusumah, Harun Achmad, Rully Marsis Amirullah Roesli, Dedi Rachmadi. "The Correlation between Fibroblast Growth Factor 23 (FGF23) and Iron Profile in Chronic Kidney Disease Patients on Dialysis with Anemia." Systematic Reviews in Pharmacy 11.6 (2020), 780-784. Print. doi:10.31838/srp.2020.6.114 APA (American Psychological Association) Style Mohammad Rudiansyah, Leonardo Lubis, Ria Bandiara, Bernadet Maria Sanjaya, Hendra Wana Nur'amin, Huldani, Abdul Hadi Martakusumah, Harun Achmad, Rully Marsis Amirullah Roesli, Dedi Rachmadi (2020) The Correlation between Fibroblast Growth Factor 23 (FGF23) and Iron Profile in Chronic Kidney Disease Patients on Dialysis with Anemia. Systematic Reviews in Pharmacy, 11 (6), 780-784. doi:10.31838/srp.2020.6.114 |
Abstract
PDF
How to cite this article